BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V204. A total of 21 filers reported holding BIOCEPT INC in Q3 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $0 | -100.0% | 2,341 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | -50.0% | 2,341 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $2,000 | -33.3% | 2,341 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $3,000 | -82.4% | 2,341 | -81.0% | 0.00% | -87.5% |
Q2 2017 | $17,000 | -93.7% | 12,341 | -90.3% | 0.01% | -94.2% |
Q1 2017 | $271,000 | +13450.0% | 127,000 | +6250.0% | 0.14% | +13700.0% |
Q4 2016 | $2,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 995,000 | $294,000 | 0.26% |
SABBY MANAGEMENT, LLC | 184,748 | $54,000 | 0.00% |
PDS Planning, Inc | 10,000 | $3,000 | 0.00% |
Creative Planning | 520,143 | $153,000 | 0.00% |
Advisory Services Network, LLC | 334 | $0 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 25,000 | $7,000 | 0.00% |
UBS Group AG | 94,937 | $28,000 | 0.00% |
Intellectus Partners, LLC | 2,341 | $1,000 | 0.00% |
US BANCORP \DE\ | 24,755 | $7,000 | 0.00% |
NORTHERN TRUST CORP | 16,490 | $5,000 | 0.00% |